Cell-specific Regulation of Hypoxia-inducible Factor (HIF)-1α and HIF-2α Stabilization and Transactivation in a Graded Oxygen Environment
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha are closely related, key transcriptional regulators of the hypoxic response, countering a low oxygen situation with the up-regulation of target genes associated with numerous processes, including vascularization and glycolysis. This involves a dual mechanism of control through both stabilization and transactivation, regulated via prolyl and asparaginyl hydroxylation. Despite high similarity with respect to protein sequence and activation pathway, a growing number of physiological and mechanistic differences between HIF-1alpha and HIF-2alpha are being reported. To further characterize this nonredundancy, the stabilization of endogenous proteins and regulation of the transactivation domains were compared in a graded oxygen environment across a series of cell lines. Although generally similar results were found, interesting and specific differences between the HIF-alpha proteins were observed within certain cell lines, such as rat adrenal PC12s, emphasizing the cell-specific nature of HIF-alpha regulation. We characterize a conserved amino acid substitution between HIF-1alpha and HIF-2alpha that contributes to the intrinsically higher FIH-1-mediated asparaginyl hydroxylation of HIF-1alpha and, hence, lower HIF-1alpha activity. In addition, our data demonstrate that the different cell lines can be classified into two distinct groups: those in which stabilization and transactivation proceed in conjunction (HeLa, 293T, and COS-1) and those cells in which HIF-alpha is stabilized prior to transactivation (PC12, HepG2, and CACO2). Interestingly, the initial stabilization of HIF-alpha prior to transactivation up-regulation predicted from in vitro derived hydroxylation data is only true for a subset of cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










![FIGURE5 Substitution of HIF-1 𝛂 A804VandHIF-2 𝛂 V848Aissufficient to swap FIH-1 mediated hydroxylation in vitro . In vitro hydroxylation assays were performed over 30 min, using 10, 40, and 80 𝛍 M purified Trx-His 6 -HIF𝛂 substrate (HIF-1 𝛂 wild type ( wt ), HIF-1 𝛂 A804V, HIF-2 𝛂 wild type, HIF-2 𝛂 V848A) and 40 𝛍 M [114 C]2-oxoglutarate. Results, obtained in triplicate and representative of three independent experiments, are presented as HIF𝛂 substrate concentration against scintillation-counted 14 C (mean ± S.D.) and fitted to a hyperbolic curve using the PRISM program.](https://figures.cochat.ai/paper-figures/d0d933fb78ca44c9adc91bd1f7667e09/cell-specific-regulation-of-hypoxia-inducible-factor-hif-1-and-hif-2-figure-5.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, HIF2α is relatively resistant to FIH1-mediated inactivation compared to HIF1α (Bracken et al., 2006; Yan et al., 2007).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Bracken et al., 2006
The cited source says what the claim attributes to it.
In the citing paper
“Of note, HIF-1α is more sensitive to FIH-1-mediated inhibition than HIF-2α (Khan et al., 2011) due to a specific amino acid difference between the two HIFs (Bracken et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Bracken et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Self-citationJiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
Wiesener, M. S., Jürgensen, J. S., Rosenberger, C., Scholze, C., Hörstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0445fje · Cited by 740
STROKA, D. M., BURKHARDT, T., DESBAILLETS, I., WENGER, R. H., NEIL, D. A. H., BAUER, C., GASSMANN, M., & CANDINAS, D. (2001) · The FASEB Journal · doi:10.1096/fj.01-0125com · Cited by 716
Research works printed but not linked: 1
- Whitelaw, M., Pongratz, I., Wilhelmsson, A., Gustafsson, J. A., and Poellinger, L. (1993) Mol. Cell. Biol. 13, 2504 -2514
Cited by
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
“Moreover, HIF2a is relatively resistant to FIH1-mediated inactivation compared to HIF1a (Bracken et al., 2006; Yan et al., 2007).”
BackgroundHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 782
“Notably, FIH appears to more efficiently hydroxylate HIF1A than HIF2A (Bracken et al., 2006; Koivunen et al., 2004).”
BackgroundThe von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin Jr, W. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2502 · Cited by 726
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
“Of note, HIF-1α is more sensitive to FIH-1-mediated inhibition than HIF2α (Khan et al., 2011) due to a specific amino acid difference between the two HIFs (Bracken et al., 2006).”
BackgroundPrabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
“Although FIH-1 hydroxylates both HIF-1 and HIF-2 , its activity for HIF-1 is significantly greater (24).”
BackgroundHypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction
Yang, S., Kim, J., Ryu, J.-H., Oh, H., Chun, C.-H., Kim, B. J., Min, B. H., & Chun, J.-S. (2010) · Nature Medicine · doi:10.1038/nm.2153 · Cited by 527
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
Shen, C., Beroukhim, R., Schumacher, S. E., Zhou, J., Chang, M., Signoretti, S., & Kaelin, W. G. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0098 · Cited by 413
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Schödel, J., Grampp, S., Maher, E. R., Moch, H., Ratcliffe, P. J., Russo, P., & Mole, D. R. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.007 · Cited by 405
“Each HIF isoform has a different transactivation capacity, in part due to different sensitivity of the C-terminal transactivation domain to hydroxylation by FIH1 [48,49], with HIF-1a being more sensitive to inactivation by FIH1.”
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 388
Hu, C.-J., Sataur, A., Wang, L., Chen, H., & Simon, M. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0419 · Cited by 355
“Our results are consistent with several reports indicating that genes such as the HIF-1 target PGK is activated by PHD2 siRNA, but not by FIH siRNA under normoxia (Bracken et al., 2006; Dayan et al., 2006; Elvidge et al., 2006).”
ResultKrieg, A. J., Rankin, E. B., Chan, D., Razorenova, O., Fernandez, S., & Giaccia, A. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00444-09 · Cited by 334
Mechanisms of hypoxia signalling: new implications for nephrology
Schödel, J., & Ratcliffe, P. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0182-z · Cited by 309
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Tam, S. Y., Wu, V. W. C., & Law, H. K. W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00486 · Cited by 298
“1% O2) whereas HIF-2α is usually up-regulated in a higher oxygen level (<5% O2) with longer maintenance time (48–72 h) in some cell lines (39, 40).”
BackgroundSomatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
Minamishima, Y. A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R. T., & Kaelin, W. G. (2008) · Blood · doi:10.1182/blood-2007-10-117812 · Cited by 294
Oxygen Sensors at the Crossroad of Metabolism
Aragonés, J., Fraisl, P., Baes, M., & Carmeliet, P. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.001 · Cited by 290
Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion
Loor, G., & Schumacker, P. T. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.13 · Cited by 277
Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis
Godet, I., Shin, Y. J., Ju, J. A., Ye, I. C., Wang, G., & Gilkes, D. M. (2019) · Nature Communications · doi:10.1038/s41467-019-12412-1 · Cited by 273
Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis
Larsen, A. K., Ouaret, D., El Ouadrani, K., & Petitprez, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.012 · Cited by 267
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Zhao, Y., Xiong, W., Li, C., Zhao, R., Lu, H., Song, S., Zhou, Y., Hu, Y., Shi, B., & Ge, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01652-9 · Cited by 249
Turn me on: regulating HIF transcriptional activity
Lisy, K., & Peet, D. J. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402315 · Cited by 233
Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Sørensen, B. S., & Horsman, M. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00562 · Cited by 229
Mechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G.-H. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 196
Yan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01514-06 · Cited by 193
“This observation is consistent with a recent study that showed that HIF2 is a poor FIH1 substrate in vitro relative to HIF1, in part because of differences in residues immediately following their respective Asn hydroxylation sites ( 1 ).”
ResultTumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Hompland, T., Fjeldbo, C. S., & Lyng, H. (2021) · Cancers · doi:10.3390/cancers13030499 · Cited by 179
“Stabilization of the HIF1 and HIF2 subunits HIF1A and EPAS1 is seen at oxygen concentrations as high as 2% O2 [6,7].”
BackgroundMethodThe HIF pathway and erythrocytosis
Lee, F. S., & Percy, M. J. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130321 · Cited by 177
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Philip, B., Ito, K., Moreno-Sanchez, R., & Ralph, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt209 · Cited by 161
“However, the contribution of the HIFs to drug resistance differs depending on the cancer type and cells of origin [8, 10].”
A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo
Minamishima, Y. A., Moslehi, J., Padera, R. F., Bronson, R. T., Liao, R., & Kaelin, W. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-09 · Cited by 161
“However, the inactivation of Phd2 alone transcriptionally activates a subset of HIF target genes (35, 52), presumably because these genes are driven by the HIF NTAD or because they are responsive primarily to HIF2 , which is fairly insensitive to FIH1 compared to HIF1 (7, 54).”
BackgroundSato, Y., Endo, H., Okuyama, H., Takeda, T., Iwahashi, H., Imagawa, A., Yamagata, K., Shimomura, I., & Inoue, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194738 · Cited by 158
HIF-1 versus HIF-2 — Is one more important than the other?
Loboda, A., Jozkowicz, A., & Dulak, J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.006 · Cited by 152
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
De Francesco, E. M., Maggiolini, M., & Musti, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072011 · Cited by 142
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00408-7 · Cited by 143
Oxygen toxicity: cellular mechanisms in normobaric hyperoxia
Alva, R., Mirza, M., Baiton, A., Lazuran, L., Samokysh, L., Bobinski, A. R., Cowan, C., Jaimon, A., Obioru, D., Makhoul, T. A., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09773-7 · Cited by 148
“, 2–6% O2) (Yan et al. 2010; Bracken et al. 2006; reviewed by Stuart et al. 2019), and it can therefore play a role in growth and development.”
BackgroundThe emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
Martin, S. K., Diamond, P., Gronthos, S., Peet, D. J., & Zannettino, A. C. W. (2011) · Leukemia · doi:10.1038/leu.2011.122 · Cited by 142
“92 differing affinities for PHD- and FIH-dependent regulation of HIF-α protein stability and transcriptional activity; and differential recruitment of isoform-specific transcriptional coactivators andsor repressors to the HIF-1 and HIF-2 complexes”
BackgroundJohansson, E., Grassi, E. S., Pantazopoulou, V., Tong, B., Lindgren, D., Berg, T. J., Pietras, E. J., Axelson, H., & Pietras, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.049 · Cited by 121
Oxygen-sensing mechanisms across eukaryotic kingdoms and their roles in complex multicellularity
Hammarlund, E. U., Flashman, E., Mohlin, S., & Licausi, F. (2020) · Science · doi:10.1126/science.aba3512 · Cited by 131
“That FIH hydroxylates the asparagine motif less efficiently onHIF-2a thanonHIF-1a could be one molecular explanation as to why HIF2a is stabilized at higher oxygen concentrations (43, 134).”
BackgroundTreatment of kidney cancer: Insights Provided by the VHL Tumor‐Suppressor Protein
Kaelin, W. G. (2009) · Cancer · doi:10.1002/cncr.24232 · Cited by 129
miR-21 in ischemia/reperfusion injury: a double-edged sword?
Xu, X., Kriegel, A. J., Jiao, X., Liu, H., Bai, X., Olson, J., Liang, M., & Ding, X. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00020.2014 · Cited by 114
“The kidney is very sensitive to hypoxia and vulnerable to ischemic or hypoxic injury because of the renal vascular anatomy and the high energy consumption of renal tubular epithelial cells (12).”
Sousa Fialho, M. D. L., Abd Jamil, A. H., Stannard, G. A., & Heather, L. C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.024 · Cited by 112
A liver Hif-2α–Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition
Wei, K., Piecewicz, S. M., McGinnis, L. M., Taniguchi, C. M., Wiegand, S. J., Anderson, K., Chan, C. W.-M., Mulligan, K. X., Kuo, D., Yuan, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3295 · Cited by 101
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
Li, M., & Kim, W. Y. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01238.x · Cited by 109
Cerebral metabolism after forced or voluntary physical exercise
Kinni, H. A., Guo, M., Ding, J. Y., Konakondla, S., Dornbos, D., Tran, R., Guthikonda, M., & Ding, Y. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.076 · Cited by 94
“When a hypoxic situation arises, the two hydroxylase enzymes lose their ability to function and the degradation of HIF-1α does not occur properly, leading to an increase in HIF-1α concentrations (Bracken et al., 2006).”
Mathew, L. K., Lee, S. S., Skuli, N., Rao, S., Keith, B., Nathanson, K. L., Lal, P., & Simon, M. C. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0291 · Cited by 92
Sim, J., Cowburn, A. S., Palazon, A., Madhu, B., Tyrakis, P. A., Macías, D., Bargiela, D. M., Pietsch, S., Gralla, M., Evans, C. E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.020 · Cited by 90
“An additional complexity is the data that indicate that the HIF-1a isoform is more susceptible to FIH modification than the other major HIF isoform, HIF-2a (Bracken et al., 2006; Koivunen et al., 2004).”
BackgroundEngelhardt, S., Huang, S., Patkar, S., Gassmann, M., & Ogunshola, O. O. (2015) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-12-4 · Cited by 100
“showed that whereas some cells readily stabilize HIF-1α at 5% O2, others require O2 levels below 1% and that HIF-1α transactivation is also dependent on the severity of the hypoxic insults in different cell types [40].”
BackgroundNovel Drugs with High Efficacy against Tumor Angiogenesis
Qi, S., Deng, S., Lian, Z., & Yu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136934 · Cited by 99
An acetate switch regulates stress erythropoiesis
Xu, M., Nagati, J. S., Xie, J., Li, J., Walters, H., Moon, Y.-A., Gerard, R. D., Huang, C.-L., Comerford, S. A., Hammer, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3587 · Cited by 87
Impact of hypoxia on DNA repair and genome integrity
Kaplan, A. R., & Glazer, P. M. (2019) · Mutagenesis · doi:10.1093/mutage/gez019 · Cited by 99
Cell-Autonomous Metabolic Reprogramming in Hypoxia
Schito, L., & Rey, S. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.006 · Cited by 89
Zhu, R., Wu, M.-Q., Li, Z., Zhang, Y., & Liu, K. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1233-4 · Cited by 88
“As an important key signal in the cellular response to the hypoxic niche [45–48], HIF-1a was proved to be a lower level in the adipocyte-inhibited mice.”
BackgroundDzhalilova, D., & Makarova, O. (2020) · Biomedicines · doi:10.3390/biomedicines8100428 · Cited by 75
Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression
Yang, G., Shi, R., & Zhang, Q. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218162 · Cited by 83
“Studies suggest that FIH inhibits HIF-1 [117] but also transcriptionally affects genes (CXCR4 and VEGFA) in an HIF-independent manner [118].”
BackgroundKunze, R., Zhou, W., Veltkamp, R. C., Wielockx, B., Breier, G., & Marti, H. H. (2012) · Stroke · doi:10.1161/strokeaha.112.669598 · Cited by 83
Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis
Stockmann, C., Kerdiles, Y., Nomaksteinsky, M., Weidemann, A., Takeda, N., Doedens, A., Torres-Collado, A. X., Iruela-Arispe, L., Nizet, V., & Johnson, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912766107 · Cited by 76
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
Brereton, C. J., Yao, L., Davies, E. R., Zhou, Y., Vukmirovic, M., Bell, J. A., Wang, S., Ridley, R. A., Dean, L. S. N., Andriotis, O. G., et al. (2022) · eLife · doi:10.7554/elife.69348 · Cited by 106
López-Codony, V., & Tavassoli, M. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101017 · Cited by 77
The Brain at High Altitude: From Molecular Signaling to Cognitive Performance
Aboouf, M. A., Thiersch, M., Soliz, J., Gassmann, M., & Gasser, E. M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210179 · Cited by 83
“Although the kinetics of stabilization and transactivation of both isoforms are similar [54], recent genome-wide studies have identified that the EPAS1 gene that encodes for HIF-2α is the major isoform involved in HA adaptation [55].”
BackgroundGregg, J. L., Turner, R. M., Chang, G., Joshi, D., Zhan, Y., Chen, L., & Maranchie, J. K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2979 · Cited by 68
Lin, X., Chen, Q., Liu, W., Zhang, J., Wang, S., Lin, Z., & Lin, J.-M. (2015) · Scientific Reports · doi:10.1038/srep09643 · Cited by 67
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Shi, Y., & Gilkes, D. M. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05537-0 · Cited by 90
Hypoxia-Inducible Factor 1 Regulation through Cross Talk between mTOR and MT1-MMP
Sakamoto, T., Weng, J. S., Hara, T., Yoshino, S., Kozuka‐Hata, H., Oyama, M., & Seiki, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01169-13 · Cited by 68
Oxygen sensing and hypoxia-induced responses
Coleman, M. L., & Ratcliffe, P. J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430001 · Cited by 65
“HIF-2 is less responsive to FIH than HIF-1 due to a conserved amino acid substitution in HIF-2 that reduces the effi ciency of asparagine hydroxylation [30].”
BackgroundHe, H., Liao, Q., Zhao, C., Zhu, C., Feng, M., Liu, Z., Jiang, L., Zhang, L., Ding, X., Yuan, M., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002755 · Cited by 67
Zhdanov, A. V., Ogurtsov, V. I., Taylor, C. T., & Papkovsky, D. B. (2010) · Integrative Biology · doi:10.1039/c0ib00021c · Cited by 67
Hypoxic pathobiology of breast cancer metastasis
Schito, L., & Rey, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.004 · Cited by 68
Low Oxygen Tension Enhances Hepatitis C Virus Replication
Vassilaki, N., Kalliampakou, K. I., Kotta‐Loizou, I., Befani, C. D., Liakos, P., Simos, G., Mentis, A. F., Kalliaropoulos, A., Doumba, P. P., Smirlis, D., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02534-12 · Cited by 64
Rani, S., Roy, S., Singh, M., & Kaithwas, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2407223 · Cited by 60
“FIH-1 is more e ff ectively inhibiting the HIF-1 α transcriptional activity, in contrast to other isoforms of HIFs [63].”
Supraphysiological Oxygen Levels in Mammalian Cell Culture: Current State and Future Perspectives
Alva, R., Gardner, G. L., Liang, P., & Stuart, J. A. (2022) · Cells · doi:10.3390/cells11193123 · Cited by 64
“investigated the stabilization of HIF-1/2α in six cell lines, HeLa, 293T, Cos-1, PC-12, CACO2, and HepG2, and they observed cell-type specific patterns [35].”
BackgroundHypoxia, pseudohypoxia and cellular differentiation
Mohlin, S., Wigerup, C., Jögi, A., & Påhlman, S. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.007 · Cited by 58
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
Khong, T. L., Thairu, N., Larsen, H., Dawson, P., Kiriakidis, S., & Paleolog, E. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-518 · Cited by 56
“These cells express functional wild-type EGFR [35], demonstrate responses to hypoxia through HIF-1 and HIF-2 regulation [10], and are frequently used as an in vitro model of CRC [36].”
BackgroundMethodDornbos, D., Zwagerman, N. T., Guo, M., Ding, J. Y., Peng, C., Esmail, F., Sikharam, C., Geng, X., Guthikonda, M., & Ding, Y. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23203 · Cited by 52
“Controlled by oxygen-dependent hydroxylase enzymes, HIF1a levels are increased following periods of hypoxia (Bracken et al., 2006), and higher HIF-1a levels are observed in rats chronically exposed to hypoxic events (Bernaudin et al., 2002).”
BackgroundChen, R., Ogunshola, O. O., Yeoh, K. K., Jani, A. R., Papadakis, M., Nagel, S., Schofield, C. J., & Buchan, A. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12804 · Cited by 55
“(2014) 131, 177--189 comparatively smaller effect on HIF-2a than HIF-1a (at least in some contexts) (Koivunen et al. 2004; Bracken et al. 2006), it is possible that IOX3 could induce production of more active HIF-2a than HIF1-a.”
BackgroundVirus–host interactions under hypoxia
Vassilaki, N., & Frakolaki, E. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.10.004 · Cited by 51
Refined control of cell stemness allowed animal evolution in the oxic realm
Hammarlund, E. U., von Stedingk, K., & Påhlman, S. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-017-0410-5 · Cited by 50
Huang, M., Yang, L., Peng, X., Wei, S., Fan, Q., Yang, S., Li, X., Li, B., Jin, H., Wu, B., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01698-5 · Cited by 58
Hypoxia-inducible factors and cancer
Calzada, M. J., & del Peso, L. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0055-y · Cited by 58
“on the cell type [114].”
The hypoxic microenvironment: a driving force for heterotopic ossification progression
Huang, Y., Wang, X., & Lin, H. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0509-1 · Cited by 51
The von Hippel‐Lindau Tumor Suppressor Protein: An Update
Kaelin, W. G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35019-2 · Cited by 51
Daly, L. A., Brownridge, P. J., Batie, M., Rocha, S., Sée, V., & Eyers, C. E. (2021) · Science Signaling · doi:10.1126/scisignal.abf6685 · Cited by 44
Wang, Y., Liu, X., Huang, W., Liang, J., & Chen, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108303 · Cited by 46
Role of HIF1 α Regulatory Factors in Stem Cells
Lee, H. J., Jung, Y. H., Choi, G. E., Kim, J. S., Chae, C. W., & Han, H. J. (2019) · International Journal of Stem Cells · doi:10.15283/ijsc18109 · Cited by 51
The Asparagine Hydroxylase FIH: A Unique Oxygen Sensor
Volkova, Y. L., Pickel, C., Jucht, A. E., Wenger, R. H., & Scholz, C. C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0003 · Cited by 44
Koizume, S., Ito, S., Miyagi, E., Hirahara, F., Nakamura, Y., Sakuma, Y., Osaka, H., Takano, Y., Ruf, W., & Miyagi, Y. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks201 · Cited by 47
Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature
Wu, D., & Birukov, K. G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00172 · Cited by 48
“…to mount a lactate response to inspired O2 levels around 10% (Huckabee, 1958), HIF-1α stabilization in vitro occurs at <5% O2 in hypoxia chambers (Bracken et al., 2006); it is therefore reasonable to assume that tissue hypoxia occurs in vivo as tissue oxygenation must be below that of arterial…”
BackgroundGenetic causes of erythrocytosis and the oxygen-sensing pathway
Lee, F. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.04.003 · Cited by 47
Functional EPAS1 / HIF2A missense variant is associated with hematocrit in Andean highlanders
Lawrence, E. S., Gu, W., Bohlender, R. J., Anza‐Ramirez, C., Cole, A. M., Yu, J. J., Hu, H., Heinrich, E. C., O’Brien, K. A., Vasquez, C. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj5661 · Cited by 43
Hillestad, T., Hompland, T., Fjeldbo, C. S., Skingen, V. E., Salberg, U. B., Aarnes, E., Nilsen, A., Lund, K. V., Evensen, T. S., Kristensen, G. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0950 · Cited by 46
“At mild hypoxia, around 2% O2, activation of the hypoxia-inducible transcription factor HIF1 promotes metabolic reprogramming and cell survival (8, 9).”
BackgroundTam, S. Y., Wu, V., & Law, H. (2020) · Cancers · doi:10.3390/cancers12010224 · Cited by 40
“Similar to Snail, TWIST1 was also significantly up-regulated in 10% O2 for both DLD-1 and SW-480, demonstrating activation by another EMT-inducing pathway other than HIF-1α under low oxygen level conditions, as HIF-1α does not activate in 10% O2 [20].”
BackgroundKhan, M. N., Bhattacharyya, T., Andrikopoulos, P., Esteban, M. A., Barod, R., Connor, T., Ashcroft, M., Maxwell, P. H., & Kiriakidis, S. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.73 · Cited by 40
“As HIF-1a is known to be a substantially better substrate for FIH-1 than HIF-2a (Bracken et al, 2006) it is likely that this resistant fraction is predominantly HIF-2a.”
BackgroundKarchner, S. I., Jenny, M. J., Tarrant, A. M., Evans, B. R., Kang, H. J., Bae, I., Sherr, D. H., & Hahn, M. E. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00206-09 · Cited by 43
Hypoxia‐induced pulmonary hypertension—Utilizing experiments of nature
Gassmann, M., Cowburn, A. S., Gu, H., Li, J., Rodriguez, M., Babicheva, A., Jain, P., Xiong, M., Gassmann, N. N., Yuan, J. X. ‐., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15144 · Cited by 44
Harvey, A. J., Kind, K. L., & Thompson, J. G. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.058826 · Cited by 42
“The activation of HIFs in response to both oxygen [36] and ‘‘mimic’’ substrates [37] is also likely to be cell-type specific.”
BackgroundRexius‐Hall, M. L., Rehman, J., & Eddington, D. (2017) · Integrative Biology · doi:10.1039/c7ib00099e · Cited by 39
HAF: The new player in oxygen-independent HIF-1α degradation
Koh, M. Y., & Powis, G. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8303 · Cited by 52
Burnley-Hall, N., Willis, G. R., Davis, J., Rees, A., & James, P. E. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.12.005 · Cited by 41
Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells
Zhdanov, A. V., Dmitriev, R. I., Golubeva, A. V., Gavrilova, S. A., & Papkovsky, D. B. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.016 · Cited by 37
“A number ofworks performed on PC12 cells describe the dynamics and regulation of HIF-1α and HIF-2α stabilization upon acute, intermittent and continuous hypoxia [29,46,47], a specificity of the NGF- and hypoxia-dependent cell differentiation [44], production and secretion of neurotransmitters [48] and generation of RO…”
BackgroundMeasuring oxygen levels in Caco-2 cultures
von Köckritz‐Blickwede, M., Zeitouni, N. E., Fandrey, J., & Naim, H. Y. (2015) · Hypoxia · doi:10.2147/hp.s85625 · Cited by 39
Zhao, W., Wang, Y., Hui, Y.-N., Zhu, J., Zhang, P., Li, X., & Dou, G. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0858-8 · Cited by 35
“HIF-1 transactivates a repertoire of genes, including VEGF, which mediate angiogenesis, cell proliferation/ survival, and glucose/iron metabolism to hypoxia [10].”
BackgroundHypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 41
Metadata
- Authors
- Bracken, C. P., Fedele, A. O., Linke, S., Balrak, W., Lisy, K., Whitelaw, M. L., & Peet, D. J.
- Affiliations
- Australian Research Council (AU)
- Corresponding author
- Peet, Daniel J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 281
- Issue
- 32
- Pages
- 22575-22585
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070254655
- Cited by
- 222
- References
- 24
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 10 · 2023: 6 · 2022: 19 · 2021: 15 · 2020: 16 · 2019: 12 · 2018: 10 · 2017: 8 · 2016: 9 · 2015: 9 · 2014: 8 · 2013: 15 · 2012: 12
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5195 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- hypoxia-inducible factor-1α, HIF-2α, HIF stabilization, prolyl hydroxylation, FIH-1, cell-specific regulation, PC12 cells, adrenal cells, transcriptional regulation
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acid Sequence, Animals, Hypoxia, Chlorocebus aethiops, Gene Expression Regulation, HeLa Cells, Humans, Molecular Sequence Data, Oxygen, Transcription Factors, Transcriptional Activation, PC12 Cells, Sequence Homology, Amino Acid, Caco-2 Cells, COS Cells, Rats, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.